ABSTRACT The function of the vacuolar H 1 -ATPase (V-ATPase) enzyme complex is to acidify organelles; this process is critical for a variety of cellular processes and has implications in human disease. There are five accessory proteins that assist in assembly of the membrane portion of the complex, the V 0 domain. To identify additional elements that affect V-ATPase assembly, trafficking, or enzyme activity, we performed a genome-wide enhancer screen in the budding yeast Saccharomyces cerevisiae with two mutant assembly factor alleles, VMA21 with a dysfunctional ER retrieval motif (vma21QQ ) and vma21QQ in combination with voa1D, a nonessential assembly factor. These alleles serve as sensitized genetic backgrounds that have reduced V-ATPase enzyme activity. Genes were identified from a variety of cellular pathways including a large number of trafficking-related components; we characterized two redundant gene pairs, HPH1/ HPH2 and ORM1/ORM2. Both sets demonstrated synthetic growth defects in combination with the vma21QQ allele. A loss of either the HPH or ORM gene pairs alone did not result in a decrease in vacuolar acidification or defects in V-ATPase assembly. While the Hph proteins are not required for V-ATPase function, Orm1p and Orm2p are required for full V-ATPase enzyme function. Consistent with the documented role of the Orm proteins in sphingolipid regulation, we have found that inhibition of sphingolipid synthesis alleviates Orm-related growth defects.
T HE vacuolar H
1 -ATPase (V-ATPase) is a multisubunit complex that is highly conserved across eukaryotes (Graham et al. 2003) . It functions to actively acidify cellular compartments by coupling the hydrolysis of ATP to the translocation of protons across membranes through a conserved rotary mechanism (Hirata et al. 2003; Yokoyama et al. 2003; Imamura et al. 2005) . Organelle acidification plays a crucial role in various cellular functions such as vesicular trafficking, endocytosis, neurotransmitter uptake, membrane fusion, and ion homeostasis (Kane 2006; Forgac 2007) . Specialized isoforms of the V-ATPase complex can be found on different cellular membranes including the plasma membrane (Forgac 2007) . A number of human diseases have been associated with or directly linked to defects in the V-ATPase complex: osteopetrosis (Frattini et al. 2000) , renal tubular acidosis (Karet et al. 1999) , and cancer cell migration (MartinezZaguilán et al. 1999) . The V-ATPase is an essential complex for all eukaryotes with the exception of some fungi.
The budding yeast Saccharomyces cerevisiae requires the V-ATPase to survive under specific environmental conditions, including alkaline conditions or otherwise toxic levels of metals (Eide et al. 2005; Kane 2006) . Yeast utilize the proton gradient created by the V-ATPase to drive sequestration of Ca 21 and Zn 21 ions within the vacuole (Klionsky et al. 1990) . A variety of protonexchange antiporter pumps reside on the vacuolar membrane and other organelles that participate in maintaining nontoxic cytosolic levels of various ions and metals including calcium and zinc (Miseta et al. 1999; MacDiarmid et al. 2002) . Deletion of any of the V-ATPase component proteins results in a number of specific growth and cellular phenotypes, including sensitivity to excess metals and a lack of vacuolar acidification. This makes yeast a useful model system to study the V-ATPase complex (Graham et al. 2003; Kane 2006) . Complete disruption of V-ATPase function in yeast results in a characteristic Vma -phenotype: failure to grow on media buffered to pH 7.5 (Kane 2006). Additionally, numerous genetic screens have demonstrated that a loss of the V-ATPase renders yeast sensitive to a variety of metals (including zinc and calcium) and drugs (Eide et al. 2005; Kane 2007) . Yeast lacking the V-ATPase complex do not acidify their vacuoles as shown through a lack of quinacrine staining (Weisman et al. 1987) .
The V-ATPase enzyme in yeast contains 14 protein subunits within two domains: the V 1 portion is responsible for hydrolyzing ATP, and the V 0 portion shuttles protons across a lipid bilayer (Forgac 2007) . The V 1 domain (subunits A-H) is peripherally associated, and the V 0 domain (subunits a, d, e, c, c9, and c99) is imbedded within the membrane except subunit d, which is a peripheral membrane protein. The functional V-ATPase enzyme requires the presence of all of these subunits. Subunit a has two isoforms in yeast, the absence of one of them is not sufficient to cause a Vma -phenotype. Yeast contain two populations of the V-ATPase complex and their localization is dictated by the incorporation of one of two isoforms of subunit a, Stv1p or Vph1p (Manolson et al. 1992 (Manolson et al. , 1994 . While higher eukaryotes contain numerous isoforms for many of the different V-ATPase subunits (Marshansky and Futai 2008) , Stv1p/Vph1p is the only structural difference between the two yeast enzymes. V-ATPase complexes containing the Vph1 protein are trafficked to the vacuolar membrane while Stv1p-containing V-ATPases are retained within the Golgi/endosomal network (Manolson et al. 1994) . Similarly, higher eukaryotes use different isoforms of subunit a to direct the localization of the V-ATPase to specific cellular compartments (Forgac 2007) . One mechanism of V-ATPase regulation occurs through the rapid, reversible dissociation of the V 1 and V 0 domains (Kane 2006) .
In the absence of any V 1 subunit, the V 0 domain is still properly assembled and targeted to the vacuole (Graham et al. 2003) . In the absence of the V 0 domain, V 1 is still assembled (Tomashek et al. 1997) . Loss of any V 0 subunit protein prevents proper V 0 assembly and ER exit (Graham et al. 2003) , and Vph1p undergoes ubiquitin-dependent ER-associated degradation (ERAD) (Hill and Cooper 2000) . Assembly of the V 0 domain occurs in the ER and requires the presence of a number of additional proteins (Forgac 2007) . Five ER-localized assembly factors have been identified in yeast that are required for full V-ATPase function yet are not part of the final complex: Vma21p, Vma22p, Vma12p, Pkr1p, and Voa1p (Hirata et al. 1993; Hill and Stevens 1995; Malkus et al. 2004; Davis-Kaplan et al. 2006; Ryan et al. 2008) . Deletion of VMA21, VMA12, or VMA22 causes a failure of the V 0 subunits to properly assembly in the ER and a complete loss of V-ATPase function, resulting in a full Vma -phenotype (Graham et al. 2003) . Yeast lacking PKR1 show a limited amount of V 0 assembly (Davis- Kaplan et al. 2006) and yeast lacking VOA1 display only a slight reduction in V-ATPase enzyme activity (Ryan et al. 2008) . Consequently, pkr1D cells score a partial Vma -phenotype while voa1D cells appear normal. Genetic screens in S. cerevisiae have been critical in identifying the components of the V-ATPase and its associated factors (Ohya et al. 1991; Ho et al. 1993; Sambade et al. 2005) . However, the most recently discovered V-ATPase assembly factor, Voa1p, was identified by proteomics and voa1D cells have no detectable growth phenotype (Ryan et al. 2008) . Voa1p physically associates with the Vma21p-V 0 complex early in V-ATPase assembly and deletion of VOA1 displays a dramatic growth phenotype in conjunction with a specific mutant allele of the VMA21 assembly factor, vma21QQ (Ryan et al. 2008) . In yeast, it has been shown that Vma21p plays a critical role in V-ATPase assembly and chaperones the completed V 0 subcomplex out of the ER to the Golgi (Hill and Stevens 1994; Malkus et al. 2004) . Vma21p is retrieved back to the ER through a conserved, Cterminal dilysine motif and participates in multiple rounds of assembly and transport (Hill and Stevens 1994; Malkus et al. 2004) . Mutation of the dilysines to diglutamine residues, as in vma21QQ, results in mislocalization of yeast Vma21p to the vacuolar membrane and a significant loss of V-ATPase function.
The identification of V-ATPase assembly factors like Voa1p that do not display a full Vma -are not likely to be found using traditional forward genetic screens. Also, pathways involved in promoting full V-ATPase function may act independently of V 1 and/or V 0 assembly and require a sensitized genetic background to produce a detectible growth phenotype. However, vma21QQ mutant yeast and, more so, the vma21QQ voa1D double mutant are two cases where the V-ATPase is partially compromised for function (Hill and Stevens 1994; Ryan et al. 2008) . We have chosen to use these two assembly mutants in genome-wide enhancer screens to identify additional factors that assist in promoting full V-ATPase function by searching for genes that will cause an increase in calcium or zinc sensitivity when deleted.
Here we report the identification of HPH1 and ORM2 in a genome-wide search for V-ATPase effectors. We describe the characterization of these two redundant yeast gene pairs, HPH1/HPH2 and ORM1/ORM2, both of which display synthetic growth defects when deleted in combination with the vma21QQ mutant. Both sets of genes were found to have specific growth phenotypes on zinc and calcium media. Deletion of either gene pair did not affect vacuolar acidification or assembly of the V 0 domain. However, deletion of ORM1 and ORM2 results in a reduction of V-ATPase activity. The Orm proteins have very recently been shown to be negative regulators of sphingolipid synthesis (Breslow et al. 2010; Han et al. 2010) . Consistent with these reports, we find that disruption of sphingolipid biogenesis is able to suppress Orm-related growth defects.
MATERIALS AND METHODS
Plasmids and yeast strains: Bacterial and yeast manipulations were done using standard laboratory protocols for molecular biology (Sambrook and Russel 2001) . Plasmids for this study are listed in Table 1 . ORM1 plus flanking sequence was amplified by polymerase chain reaction (PCR) from BY4741 (Invitrogen, Carlsbad, CA) genomic DNA using primers containing an upstream BamHI restriction site and downstream SalI restriction site. This fragment was inserted into pCR4Blunt-TOPO (Invitrogen), digested, and ligated into the BamHI and SalI sites of YEp351 to create pGF127. pGF87 was created using homologous recombination and in vivo ligation by gapping pRS415 and cotransforming a PCR fragment containing prVPH1TVPH1TGFPTSp_HIS5 (amplified from pGF06) with flanking sequence to the pRS415 vector.
Yeast strains used in this study are listed in Table 2 . GFY164 was created by PCR amplifying the hph1DTKan R cassette plus 500 bp flanking sequence from corresponding BY4741 strains of the genome deletion collection (Open Biosystems, Huntsville, AL). It was subcloned into pCR4Blunt-TOPO, reamplified by PCR, transformed into SF838-1Da, and selected on YEPD plus G418 (Gold Biotechnology, St. Louis, MO). Strains containing deletion cassettes other than Kan R (Hyg R or Nat R ) were created by PCR amplifying either the Hyg R or Nat R cassette from pAG32 or pAG25, respectively (Goldstein and McCuster 1999) and transforming the fragment into the corresponding Kan R genome deletion strain to exchange drug resistance markers. Deletions in the SF838-1Da strain (GFY164, GFY165, GFY166, GFY168, GFY169, and GFY170) were constructed by PCR amplifying the appropriate gene locus (including 500 bp of 59-UTR and 39-UTR flanking sequence), transforming into wild-type (WT) SF838-1Da, and selecting for the appropriate drug resistance. GFY167, GFY171, and GFY172 were created using LGY183 as the parental strain. GFY173 was created using MRY5 as the parental strain. All deletion strains in SF838-1Da were confirmed by diagnostic PCR from genomic DNA with primers complementary to the 59-UTR (750-1000 bp upstream of the start codon) and internal to the drug resistance gene. A disruption cassette was created to delete TSC3 by first PCR amplifying the TSC3 open reading frame with 500 bp of flanking UTR, subcloning in pCR4Blunt-TOPO, and introducing a unique restriction site within the ORF. The TSC3 gene was subcloned into pRS316 and the entire ORF was replaced by the Nat R cassette using homologous recombination. The deletion cassette was amplified and cloned into pCR4Blunt-TOPO for use in creating both GFY174 (using SF838-1Da as the parental strain), GFY175 (using GFY170 as the parental strain), and GFY313 (using MRY5 as the parental strain). pGF20 was created by first swapping GFP for mCherry (Shaner et al. 2004) in pRS316 VMA2-GFP and introducing a unique PmeI restriction site downstream of mCherry using site-directed mutagenesis. Second, in vivo ligation was used to insert the ADH1 terminator and Nat R cassette at the 39 end of VMA2-mCherry. A single, C-terminal mCherry (PCR amplified from pGF20 including the Nat R cassette) was integrated at the VMA2 locus in strains GFY170, SF838-1Da, and TASY006. This created yeast strains GFY302, GFY304, and GFY305, respectively.
The synthetic genetic array (SGA) query strains were created from yeast parental strain Y7092 (Tong and Boone 2006) . After PCR amplifying the vma21QQTHATNat R locus with 500 bp of flanking sequence from GFY163 genomic DNA, the PCR product was transformed into Y7092 to create GFY36. To create GCY3, GCY2 (vma21QQTHA voa1DTKan R ) was transformed with the Nat R cassette to replace the Kan R cassette. Both the VMA21 and VOA1 loci were PCR amplified with flanking sequence and the PCR product was transformed into Y7092. GFY104 was created by PCR amplifying both the VMA21 and VOA1 loci from MRY5 (vma21QQTHA voa1THyg R ) with 500 bp of flanking sequence and transforming the fragment into GCY3.
Culture conditions: Yeast were cultured in YEPD (1% yeast extract, 2% peptone, and 2% dextrose), YEPD buffered to pH 5.0 using 50 mm succinate/phosphate plus 0.01% adenine, or synthetic minimal media with dextrose (SD) and the appropriate amino acids. Growth tests were performed by culturing exponentially growing yeast in rich medium to a cell density of 1.0 OD 600 , serially diluted fivefold, and spotted onto agar plates. Plates used included YEPD pH 5.0, YEPD 1 4.0 mm or 5.0 mm ZnCl 2 , YEPD 1 100 mm CaCl 2 , and YEPD 1 25 mm or 50 mm CaCl 2 pH 7.5 (using 50 mm HEPES).
Synthetic genetic array screen: A synthetic genetic enhancer screen was performed as previously described (Tong et al. 2001; Tong and Boone 2006) . Briefly, the query strains (GFY36, GCY3, and GFY104) were mated to the MATa haploid genome deletion collection (BY4741, his3D1 leu2D0, met15D0, ura3D0) and double or triple haploid mutants were selected. The final haploid mutant array was spotted onto YEPD pH 5.0, YEPD 1 ZnCl 2 , or YEPD 1 CaCl 2 pH 7.5 and incubated at 30°f or 2-3 days. Scans of each plate were visually scored for colony size on each plate type used; colonies were scored for increased sensitivity to calcium or zinc. The genome deletion collection was also arrayed under identical conditions and scored in the same way. Colonies that showed equivalent sensitivity to either metal as a single deletion strain and as part of the double (or triple) mutant collection were not scored as positive hits. Only mutants that displayed a synthetic growth defect that was not present (or not as strong) in either of the single mutant strains were scored as positive hits. Gene ontology (GO) analysis was performed using the Saccharomyces Genome Database (SGD) GO term finder (version 0.83) using a P-value cutoff of 0.01.
Whole cell extract preparation and immunoblotting: Whole cell extracts were prepared as previously described (Ryan et al. 2008) . Briefly, cultures were grown overnight in SD dropout media and then diluted to 0.25 OD 600 /ml in YEPD pH 5.0 and grown to a cell density of OD 600 ¼ 1.0. A total of 10 OD 600 of the culture was centrifuged, resuspended in 0.25 ml Thorner buffer (8 m urea, 5% SDS, and 50 mm TRIS pH 6.8), and vortexed with 0.2 ml of glass beads. Following centrifugation, protein concentrations were determined using a modified Lowry protein assay (Markwell et al. 1978) . Equal amounts of protein were separated by SDS-PAGE, transferred to nitrocellulose membrane, and probed with antibodies. Antibodies used Fluorescence microscopy: Yeast were stained with quinacrine as previously described (Flannery et al. 2004) . Briefly, cells were grown overnight in YEPD pH 5.0 plus adenine, and diluted to a cell density of 0.25 OD 600 /ml in YEPD. Yeast were harvested at a density of 0.8-1.0 OD 600 /ml and 1 ml of culture was placed on ice for 5 min. Cells were pelleted and resuspended in 200 mm quinacrine, 100 mm Hepes pH 7.6, and 50 mg/ml of concanavalin A tetramethylrhodamine (Invitrogen) in YEPD for 10 min at 30°. Following staining with quinacrine, cells were placed on ice and washed three times in 100 mm Hepes pH 7.6 plus 2% glucose (4°). Microscopy images were obtained using an Axioplan 2 fluorescence microscope (Carl Zeiss, Thornwood, NY). A 3100 objective was used as well as AxioVision software (Carl Zeiss).
V-ATPase activity assay: Yeast vacuoles were isolated from wild-type (SF838-1Da and BY4741), vma21DTKan
, and hph1DTKan R hph2DTHyg R (GFY166 and GFY181) strains as previously published (Uchida et al. 1985) . Modifications to this protocol included harvesting cells at 1.8-2.2 OD 600 /ml and use of a tighter-fitting dounce homogenizer (five strokes). Fresh vacuoles were assayed by a coupled spectrophotometric assay (Conibear and Stevens 2002) . In this assay system, ATP hydrolysis is coupled to NADH oxidation (340 nm) in a reaction mixture containing 50 mg/ml vacuole membrane protein, 25 mm MES, 25 mm MOPS, 25 mm KCl, 5 mm MgCl 2 , 1 mm NaN 3 , 0.05 mm Na 3 VO 4 , 2 mm phosphoenolpyruvate, 0.5 mm NADH, 30 units/ml pyruvate kinase, and 37 units/ml lactate dehydrogenase; pH 7 (KOH), with and without 1 mm concanamycin A. Reactions were initiated by adding Mg 21 -ATP to 2 mm and thermostatted at 30°. For each mutant strain, one to three separate vacuole preparations were assayed, and the assay was repeated two to six times for each preparation. Concanamycin A-sensitive ATPase activities were determined by calculating the activity as a percentage of wild-type activity for each biological replicate. For samples with multiple vacuole preparations, these percentages were averaged and the error was presented as the standard error of the mean. For samples with only a single biological preparation, the error is presented as the standard deviations for replicate assays.
RESULTS
Genome-wide SGA screen for V-ATPase effectors: To identify new genes that assist in promoting full V-ATPase function, we performed three SGA Vma -enhancer screens using the S. cerevisiae haploid deletion mutant collection (4741 mutants). Since a loss of VOA1 only displayed a synthetic growth defect upon combination with the vma21QQ mutation, additional (Ryan et al. 2008) . Therefore, the voa1DTNat R allele served as an additional sensitized genetic background.
Yeast that contain Vma21p having the mutated retrieval/retention signal, vma21QQ, show a partial growth defect on elevated calcium media buffered to pH 7.5 and have reduced V-ATPase activity (Hill and Stevens 1994; Ryan et al. 2008) . Additionally, vma21QQ voa1D yeast are also compromised for V-ATPase function yet do not display a full Vma -phenotype (Ryan et al. 2008) .
The haploid double or triple mutant yeast were plated onto rich media and media containing either zinc (2.75 mm or 7.0 mm) or calcium (50 mm or 100 mm) buffered to pH 7.5 in quadruplicate. Yeast that displayed increased sensitivity to these conditions were scored as positive hits. Genes were identified from a diverse set of cellular processes such as protein modification, metabolism, chromatin remodeling, and transcriptional regulation ( Figure 1 and supporting information, Table S1 ). A comprehensive GO analysis was performed for categories of genes that were enriched in our SGA screens (Table S2 ). Some of the most highly enriched categories included vacuolar transport (P-value of 4.94 3 10 À17 ), vesicle-mediated transport (P-value of 3.48 3 10 À15 ), and intracellular transport (P-value of 9.46 3 10 À10 ). Genes identified by the three SGA screens that correspond to elements of protein trafficking, vacuolar morphology, and the V-ATPase complex are listed in Table 3 and several were chosen for further study.
Since we were searching for genes that showed increased sensitivity to zinc or calcium when deleted in combination with vma21QQ or vma21QQ voa1D, we did not identify any of the essential V-ATPase subunits or assembly factors (those with a VMA designation) as expected. Also, VOA1 was not identified in the vma21QQ SGA screen because it is genetically linked to the VMA21 locus. For the voa1D locus to be paired with the vma21QQ mutation during the SGA protocol, a crossover event would be required between these two loci. However, we did identify V-ATPase subunits VPH1, STV1, the assembly factor PKR1, and genes within the vacuolar transporter chaperone (VTC) and regulator of vacuolar and endosomal membrane (RAVE) complexes.
In addition, genes involved in ER-resident processes including protein folding and degradation were identified (Table 3) . A number of genes were found that have been poorly characterized according to the SGD and these were most interesting to us. We chose to examine Orm2p for further study because it was an ER-localized, integral membrane protein. Also, Hph1p has been identified as an ER-localized binding partner of calcineurin (Heath et al. 2004 ). Due to the genetic link between calcineurin and the V-ATPase (Tanida et al. 1995) , we also chose HPH1 for further study.
HPH1/HPH2 or ORM1/ORM2 null mutants cause synthetic growth defects in vma21QQ yeast: The hph1D mutation was moved to the SF838-1Da genetic background and carefully tested by serial dilution in comparison to Vma -and Vma-compromised strains. The growth phenotypes of vma21QQ voa1D yeast deleted for HPH1 were tested on media containing 50 mm calcium buffered to pH 7.5 ( Figure 2A ). Whereas wild-type yeast were able to grow under these conditions, yeast deleted for VMA21 were unable to grow as they lack functional V-ATPase complexes. vma21QQ voa1D yeast showed a compromised level of growth under these conditions and a deletion of HPH1 in this strain caused a further increase in sensitivity (Figure 2A ). HPH1 has a homolog in S. cerevisiae, HPH2, and both Hph1p and Hph2p reside in the ER membrane (Heath et al. 2004) . It has been reported that deletions in HPH1 and HPH2 display a synthetic growth defect under alkaline conditions of pH 8.8 (Heath et al. 2004) . Since a reduction in V-ATPase function results in increased sensitivity to calcium or zinc, we determined whether a loss of the HPH genes results in a metal-specific phenotype. Loss of either HPH1 or HPH2 did not result in any sensitivity to excess zinc yet deletion of both HPH genes caused a dramatic growth defect on 5.0 mm ZnCl 2 ( Figure 2B ). Both HPH1 and HPH2 were also deleted in a strain containing the vma21QQ mutation and tested on the less stringent conditions of 4.0 mm ZnCl 2 . Both vma21QQ and hph1D hph2D yeast grew comparable to À phenotype. Genes were categorized according to their presumed molecular function. The miscellaneous category includes lipids/sphingolipids, cellular morphogenesis, nuclear import, and several other processes, and also genes with no molecular characterization. A comprehensive list of all genes identified can be found in Table S1 and a comprehensive GO analysis can be found in Table S2. WT but the vma21QQ hph1D hph2D mutant was fully sensitive under these conditions and unable to grow ( Figure 2C ). Interestingly, the hph1D hph2D double mutant did not show any sensitivity to 4.0 mm ZnCl 2 but displayed a dramatic shift in sensitivity between 4.0 mm and 5.0 mm ZnCl 2 .
The SGA screens also identified cells lacking ORM2 as an enhancer of the assembly factor mutant strains vma21QQ and vma21QQ voa1D on media containing either zinc or calcium. The orm2D was recreated in SF838-1Da cells expressing vma21QQ and tested on media containing 25 mm calcium buffered to pH 7.5. Loss of ORM2 in vma21QQ yeast caused a slight increase in the sensitivity of this strain compared to vma21QQ yeast ( Figure 3A ). ORM2 has a homolog in S. cerevisiae, ORM1, and the double orm1D orm2D mutant shows synthetic growth defects under various environmental stress conditions including elevated mercury or the reducing agent DTT (Hjelmqvist et al. 2002) . We tested whether a loss of both ORM1 and ORM2 caused an increase in sensitivity to 25 mm calcium at pH 7.5. While deletion of ORM1 did not result in any growth defect, yeast deleted for ORM2 were partially sensitive under these conditions ( Figure 3B ). However, the orm1D orm2D double mutant displayed a synthetic growth defect under these conditions. Due to the high similarity between ORM1 and ORM2 ($67% identical), we tested whether ORM1 and ORM2 are functionally redundant. Overexpression of Orm1p was able to fully rescue the growth defect of an orm2D strain ( Figure 3C ). These data suggest that ORM1 and ORM2 are a functionally redundant gene pair; we chose to examine the effect of a loss of both Orm1p and Orm2p on the V-ATPase.
Finally, we compared the growth of vma21QQ and orm1D orm2D yeast to the triple vma21QQ orm1D orm2D mutant using less stringent conditions of unbuffered 100 mm CaCl 2 . Since a loss of both ORM1 and ORM2 was only sensitive under stringent growth conditions, we tested whether reducing V-ATPase function using the vma21QQ mutant would result in a more dramatic growth phenotype. Similar to the HPH1/2 genes, a loss of both ORM genes in vma21QQ yeast caused a severe growth defect ( Figure 3D ). This suggests that the ORM genes are required when V-ATPase activity is reduced. Genes identified by genome-wide SGA screens for V-ATPase effectors that are trafficking related or whose protein products are ER localized
Trafficking-related genes AP-3 (4) apl5D, apl6D, apm3D, aps3D Vesicle formation (5) arf1D, cdc50D, drs2D, vps1D, yap1801D Rabs/vesicle targeting factors (5) gyp1D, sro7D, vps21D, vps9D, ypt7D TGN trafficking (11) age2D, arl1D, arl3D, cog5D, cog6D, cog7D, cog8D, coy1D, gyp36D, sys1D, vps13D ESCRT/MVB sorting (13) vps2D, vps22D, vps23D, vps24D, vps25D, vps27D, vps36D, vps37D, vps4D, vps46D, vps55D, vps60D, vta1D Vacuole inheritance (2) cla4D, vac8D HOPS/CORVET (4) vam6D, vps3D, vps33D, vps41D Endocytosis/exocytosis (6) chs5D, chs6D, gsf2D, lst4D, rcy1D, drs2D ER-Golgi trafficking (12) bst1D, erd1D, erp3D, erv46D, gcs1D, get1D, get2D, get3D, gsg1D, pho86D, sec28D, ubp3D Autophagy (5) atg15D, atg21D, atg27D, atg8D, vps62D GARP (2) vps52D, vps53D SNAREs and fusion (8) gos1D, pep12D, sec22D, snx4D, swf1D, tlg2D, vam10D, vam7D Phosphatidylinositol synthesis (3) inp53D, sac1D, vac14D Retromer (5) vps17D, vps26D, vps29D, vps35D, vps5D H 1 -V-ATPase (7) pkr1D, rav1D, rav2D, stv1D, vph1D, vtc1D, vtc4D Miscellaneous (5) apm1D, ccz1D, mon1D, vps19D, yck3D
Genes whose protein products are ER localized Protein degradation (2) cue1D, ubc7D Protein import and maturation (5) cne1D, cwh41D, emc1D, scj1D, sec66D Miscellaneous (18) alg6D, alg8D, bsd2D, csg2D, erg3D, erg6D, flc2D, hph1D, ice2D, ilm1D, mga2D, orm2D, ost3D, ost4D, per1D, scs2D, spf1D, sur4D
Genes found in our screens that are involved in either protein trafficking or are ER localized are listed above. A comprehensive list of all genes identified in all three screens can be found in Table S1 . Screens were performed with query strains vma21QQ voa1THyg R (GFY104), vma21QQ voa1DNat R (GCY3), and vma21QQ-Nat R (GFY36). Colonies from the final double or triple mutant strains were analyzed for fitness defects on rich media plus 2.75 mm or 7.0 mm ZnCl 2 or rich media buffered to pH 7.5 plus 50 mm or 100 mm CaCl 2 . The haploid deletion library was also tested and scored under identical media conditions. Fitness defects of single knockout strains were noted and considered when determining synthetic growth effects. HPH1 and ORM2 (shown in boldface type) were chosen for further study. A comprehensive gene ontology (GO) analysis for enriched categories of genes can be found in Table S2 .
Vacuolar acidification, V 0 assembly, and V-ATPase localization are normal in HPH and ORM mutants: Yeast disrupted for V-ATPase function show decreases in vacuolar acidification (Davis-Kaplan et al. 2006; Ryan et al. 2008) . To determine whether the growth defects seen with both the HPH and ORM mutants result from a loss of V-ATPase function, we assayed vacuolar acidification by fluorescent staining with quinacrine ( Figure  4 ). Wild-type yeast displayed accumulation of quinacrine within the acidified vacuole while vma21D yeast showed no quinacrine staining. As previously shown, yeast mutant for either vma21QQ or voa1D displayed wild-type levels of quinacrine staining and vacuolar acidification (Ryan et al. 2008 ; Figure 4 ). As expected, the vma21QQ voa1D double mutant accumulated a very low level of quinacrine (Figure 4) . Surprisingly, both the double mutants (hph1D hph2D and orm1D orm2D ) and the triple mutant (vma21QQ hph1D hph2D) had fully acidified vacuoles (Figure 4) . Only the vma21QQ orm1D R hph1D (21QQ voa1D hph1D; GFY173) were serially diluted and spotted onto rich media buffered to pH 5.0 or rich media buffered to pH 7.5 plus 50 mm CaCl 2 . (B) Exponentially growing cultures of wild type, hph1D (hph1D; GFY164), hph2D (hph2D; GFY165), and hph1D hph2D (hph1D hph2D; GFY166) were spotted onto rich media or rich media plus 5.0 mm ZnCl 2 . (C) Cultures of wild type, vma21D, vma21QQ (21QQ; LGY183), hph1D hph2D, and vma21QQ hph1D hph2D (21QQ hph1D hph2D; GFY167) were serially diluted and spotted onto rich media buffered to pH 5.0 or rich media plus 4.0 mm ZnCl 2 . LGY183), and vma21QQ orm2D (21QQ orm2D; GFY171) were serially diluted and spotted onto rich media buffered to pH 5.0 or rich media buffered to pH 7.5 plus 25 mm CaCl 2 . (B) Cultures of wild type, orm1D (orm1D; GFY168), orm2D (orm2D; GFY169), and orm1D orm2D (orm1D orm2D; GFY170) spotted onto rich media and rich media buffered to pH 7.5 plus 25 mm CaCl 2 . (C) Cultures of wild type, orm2D, and orm2D transformed with a high-copy vector expressing ORM1 were spotted onto rich media and rich media buffered to pH 7.5 plus 50 mm CaCl 2 . (D) Exponentially growing cultures of wild type, vma21D, vma21QQ, orm1D orm2D, and vma21QQ orm1D orm2D (21QQ orm1D orm2D; GFY172) were serially diluted and spotted onto rich media buffered to pH 5.0 or rich media plus 100 mm CaCl 2 .
orm2D mutant displayed a partial loss of quinacrine staining, indicating reduced V-ATPase function.
While there was no detectable difference in vacuolar acidification, it is possible that the HPH and ORM mutants have slightly reduced levels of the V-ATPase present on the vacuole that might not be apparent using fluorescent microscopy but still be consistent with the observed growth phenotypes. We assayed the levels of Vph1p within these mutant strains by Western blotting to examine any defects in V 0 assembly ( Figure 5 ). In wild-type yeast, Vph1 protein is extremely stable (.4-hr half-life; Graham et al. 1998; Hill and Cooper 2000) and incorporated into the V 0 subcomplex. However, Vph1p is rapidly degraded (25-30 min half-life) if there is a V 0 assembly defect in the ER (Graham et al. 1998; Hill and Cooper 2000) . As predicted, the levels of Vph1p in vma21D yeast were greatly reduced compared to wild-type levels. In contrast, voa1D, hph1D hph2D, and orm1D orm2D yeast all displayed wild-type levels of Vph1p. This result indicates there is no V 0 assembly defect in these strains that would result in increased turnover of Vph1p. The vma21QQ mutant showed a slight decrease in Vph1p levels. Careful analysis has shown that this decrease was mirrored in HPH and ORM mutant strains also containing the vma21QQ mutation (vma21QQ hph1D hph2D and vma21QQ orm1D orm2D). Only vma21QQ voa1D yeast showed a clear reduction in Vph1p that was greater than that seen in the vma21QQ mutant. The ER-resident protein Dpm1p was probed as a loading control. The steady-state levels of the V 1 subunit Vma1p did not change in any of the queried mutants.
The localization of the V-ATPase was also examined in both the ORM and HPH mutant strains. Yeast expressing both the V 0 subunit Vph1p-GFP and the V 1 subunit Vma2p-mCherry were visualized by fluorescent microscopy. In wild-type yeast, Vph1p-GFP localized to the limiting membrane of the vacuole and colocalized with Vma2p-mCherry ( Figure 6 ). There was also a pool of Vma2p-mCherry staining within the cytosol in a diffuse pattern. In vma21D yeast, Vph1p-GFP was found in both cortical and perinuclear ER structures and Vma2p-mCherry was only localized within the cytosol. Yeast mutant for orm1D orm2D showed both V 0 and V 1 localized to the vacuolar membrane similar to wild-type cells (Figure 6 ). Strains mutant for hph1D hph2D localized Vph1p-GFP to the vacuole (data not shown).
Loss of the ORM genes (but not the HPH genes) results in reduced V-ATPase enzyme activity: Since it is possible that the growth defects seen in the HPH and ORM strains could result from defects in V-ATPase enzyme function (rather than from assembly defects), we performed V-ATPase activity assays on isolated vacuole membranes in these mutant strains. We measured vacuole membranes from the hph1D hph2D strain to have 88% V-ATPase activity, whereas the orm1D orm2D mutant had 67% activity relative to wild-type yeast (Table  4) . We also tested V-ATPase enzyme activity for the hph1D hph2D mutant in a separate genetic background (BY4741) and found no difference from wild-type vacuole membranes (116% of WT; Table 4 ). We determined the vma21QQ mutant activity to be 22% of wild-type yeast despite the appearance of fully acidified vacuoles. The double vma21QQ voa1D mutant showed a dramatic decrease to 9%. The vma21QQ orm1D orm2D triple mutant had a comparable reduction of V-ATPase activity to 8% relative to wild-type yeast. These results indicate that the Hph proteins do not affect the activity of the V-ATPase and that the Orm proteins are required for full V-ATPase function. LGY183), voa1TH (voa1D; MRY14), vma21QQ voa1TH (21QQ voa1D; MRY5), hph1D hph2D (hph1D hph2D; GFY166), and vma21QQ hph1D hph2D (21QQ hph1D hph2D; GFY167), orm1D orm1D (orm1D orm2D; GFY170), and vma21QQ orm1D orm2D (21QQ orm1D orm2D; GFY172) were stained with quinacrine (green) and concanavalin A-tetramethylrhodamine (red) and viewed by fluorescent and DIC microscopy.
The Orm proteins function in sphingolipid regulation: Two reports have recently demonstrated that Orm1p and Orm2p are negative regulators of the serine palmitoyltransferase (SPT) complex responsible for the first and rate-limiting enzymatic step of sphingolipid synthesis (Breslow et al. 2010; Han et al. 2010) . Since loss of Orm1p and Orm2p has been shown to result in increased sphingolipid production (Breslow et al. 2010; Han et al. 2010) , we tested whether inhibition of the SPT complex alleviated the defects seen in an orm1D orm2D mutant. Tsc3p is a small protein that associates with the SPT enzyme and is required for full activity of this complex (Gable et al. 2000) . We deleted TSC3 in the orm1D orm2D mutant and tested the triple mutant strain on media containing elevated calcium and buffered to pH 7.5 ( Figure 7A ). Yeast lacking TSC3 did not display any growth defect under these conditions. However, loss of TSC3 allowed for increased growth of the orm1D orm2D strain. Additionally, suppression by deletion of TSC3 was specific to the orm1D orm2D mutant, as loss of this regulator did not suppress the calcium sensitivity of the vma21QQ voa1D mutant ( Figure  7B ). These results suggest that the growth defects seen in the orm1D orm2D mutant strain are due to perturbation of sphingolipid synthesis.
DISCUSSION
The goal of this study was to identify additional factors that contribute to V-ATPase function that may have been missed by previous forward genetic screens. The power of enhancer and suppressor screens is evident from work in both Drosophila melanogaster and Caenorhabditis elegans where it is often necessary to use a sensitized background to uncover new genetic pathways ( Jorgensen and Mango 2002; St Johnston 2002) . In the case of the yeast V-ATPase, parallel genetic pathways are most likely not the main obstacles for identifying subtle effectors of this complex. Instead, the V-ATPase enzyme within the cell requires a dramatic decrease in enzyme function or assembly before cellular growth phenotypes become evident (Ryan et al. 2008) . The discovery of the fourth and fifth factors that participate in V 0 assembly (Pkr1p and Voa1p) demonstrates the complexity of the assembly processes required for the V-ATPase enzyme complex. While Voa1p has been shown to physically associate with the V 0 subcomplex in the ER (Ryan et al. 2008) , no physical association has been characterized for Pkr1p despite a strong genetic link to the assembly factor Vma21p (Graham and Stevens 1998; Davis-Kaplan et al. 2006 ; data not shown). Growth phenotypes associated with perturbation of the V-ATPase are only evident upon a significant reduction in enzyme activity to $20% of wild type as in the case of the mutant assembly factor allele, vma21QQ (Hill and Stevens 1994) . This retrieval-defective mutant allele of the highly conserved assembly factor, Figure 5 .-Vph1p levels are not reduced in strains lacking either HPH1/HPH2 or ORM1/ORM2. Whole cell extracts were prepared from wild type (WT; SF838-1Da), vma21D (21D; TASY006), vma21QQ (21QQ; LGY183), voa1TH (voa1D; MRY14), vma21QQ voa1TH (21QQ voa1D; MRY5), hph1D hph2D (hph1D hph2D; GFY166), and vma21QQ hph1D hph2D (21QQ hph1D hph2D; GFY167), orm1D orm1D (orm1D orm2D; GFY170), and vma21QQ orm1D orm2D (21QQ orm1D orm2D; GFY172). Proteins were separated by SDS-PAGE and probed with anti-Vph1p and anti-Vma1p antibodies. Anti-Dpm1p antibody was used as a loading control. The molecular mass (kilodaltons) of the nearest marker is shown on the left. Figure 6 .-V 1 and V 0 are localized to the vacuole membrane in Orm mutant yeast. A single mCherry was integrated at the VMA2 locus in the following strains: wild type (WT; GFY304), vma21D (21D; GFY305), and orm1D orm2D (orm1D orm2D; GFY302). Yeast strains also contained a vector expressing Vph1p-GFP (pGF87). Exponentially growing cells were visualized by fluorescent and DIC microscopy.
Vma21p, is a unique scenario to serve as a genetic tool for enhancer (and suppressor) screens because (i) the levels of functional V-ATPase are sufficiently low to allow for phenotypic scoring, and (ii) the V-ATPase is not compromised for enzyme function, but rather, is defective for assembly due to the limited supply of Vma21p in the ER.
In performing genome-wide enhancer screens with the vma21QQ and vma21QQ voa1D alleles, a large number of genes involved in vesicular trafficking pathways, endosomal sorting complex required for transport (ESCRT) machinery, vesicle formation, and vacuolar morphology were identified. Deletion of some trafficking-related genes has been shown to result in sensitivity to zinc, calcium, or alkaline conditions (Serrano et al. 2004; Sambade et al. 2005; Pagani et al. 2007) . Our strategy for screening effectively detected reduced VATPase activity levels to $10% of wild-type yeast (scored as ,50% of activity in the vma21QQ mutant strain). It is therefore not surprising that we have identified additional genes involved in trafficking pathways that were not previously found in forward genetic screens. For instance, many of the vacuolar protein sorting (VPS) genes have not been identified in previous genomewide screens for Vma -phenotypes (Sambade et al. 2005) . The genetic relationship between these sorting pathways and vacuolar acidification most likely results from aberrant sorting of the V-ATPase. There are many ways by which disruption of vesicular trafficking can result in mislocalization of the V-ATPase enzyme. For example, loss of the AAA-ATPase Vps4p results in an aberrant multivesicular body that traps vacuole-bound 22 6 1 (3) 1111 vma21QQ voa1D 9 6 0.5 (2) 1 vma21QQ orm1D orm2D 8 6 0.5 (2) 11
Loss of both ORM1 and ORM2 results in a decrease in V-ATPase activity. Activity assays were performed for wild-type strains (WT; SF838-1Da and WT; BY4741), vma21D (vma21D; TASY006), vma21QQ (vma21QQ; LGY183), voa1TH (voa1D; MRY14), orm1D orm1D (orm1D orm2D; GFY170), vma21QQ voa1TH (vma21QQ voa1D; MRY5), hph1D hph2D SF838-1Da (hph1D hph2D; GFY166), hph1D hph2D BY4741 (hph1D hph2D; GFY181), and vma21QQ orm1D orm2D (vma21QQ orm1D orm2D; GFY172). A continuous, coupled spectrophotometric assay (Conibear and Stevens 2002) was used to assay freshly prepared vacuole membranes for concanamycin A-sensitive ATPase activity. The wild-type strain SF838-1Da had an average specific activity of 0.817 mmol min À1 mg
À1
(average of n ¼ 7 independent vacuole isolations) and the wild-type strain BY4741 has a specific activity of 0.836 mmol min À1 mg À1 (1 vacuole isolation). The specific activity of mutant samples was divided by the wild-type specific activity measurement for each independent vacuolar preparation to produce a relative percentage. For samples prepared more than once (biological replicates indicated in parentheses), the different percentages were averaged to produce the percentage of wild-type activity measurements 6 the standard error of the mean. Quinacrine staining is derived from Figure 3 .
a Data not shown. Cultures of wild type (WT; SF838-1Da), vma21D (21D; TASY006), tsc3D (tsc3D; GFY174), orm1D orm2D (orm1D orm2D; GFY170), and orm1D orm2D tsc3D (orm1D orm2D tsc3D; GFY175) were spotted onto rich media and media containing 25 mm CaCl 2 buffered to pH 7.5. (B) Wild type, vma21QQ voa1D (21QQ voa1D; MRY5), tsc3D, and vma21QQ voa1D tsc3D (21QQ voa1D tsc3D; GFY313) yeast were spotted onto rich media and media containing 100 mm CaCl 2 . cargo in this compartment (Raymond et al. 1992) . In addition, loss of the syntaxin Pep12p (another class of trafficking mutants) results in mislocalization of Vph1p (Gerrard et al. 2000) . If the V-ATPase is not targeted to the vacuolar membrane, the pH gradient necessary to drive the sequestration of excess metals is not established, and the result is an increased sensitivity in our screen. Due to the complexity of protein sorting from the Golgi to the vacuole, there are many components that are required for proper transport of the V-ATPase to the vacuole membrane (Bowers and Stevens 2005) . It will be of interest to determine whether disruption of other trafficking pathways is able to affect metal sensitivity without perturbation of V-ATPase localization and function.
We chose to characterize two gene families, HPH1 and ORM2, whose protein products had been previously reported to localize to the ER; both have homologs within budding yeast, HPH2 and ORM1, respectively (Hjelmqvist et al. 2002; Heath et al. 2004) . HPH1 and HPH2 have been characterized as new components of calcineurin signaling (Heath et al. 2004) . Genetic screens have also found that deletion of any of the essential subunits of the V-ATPase is synthetic lethal with a loss of calcineurin (Tanida et al. 1995; Parsons et al. 2004) . We therefore investigated the involvement of the Hph proteins in the function and/or assembly of the V-ATPase complex in the ER.
HPH1 and HPH2 have been previously reported to be functionally redundant and sensitive to high salinity or alkaline conditions (Heath et al. 2004) . We have found a unique set of growth phenotypes associated with a loss of HPH1 and HPH2 on media containing excess metals. The hph1D hph2D mutant did not display any sensitivity to elevated calcium (data not shown) yet displayed a nonlinear shift in zinc sensitivity. This was unusual, as our previously observed V-ATPase mutants with a partial reduction in function, pkr1D, vma21QQ, and vma21QQ voa1D (data not shown), exhibit growth defects on both zinc and calcium to varying degrees and have a gradual response to increasing concentrations of ZnCl 2 . Preliminary work has also demonstrated that the zinc sensitivity of the hph1D hph2D mutant was not completely dependent on calcineurin (data not shown). On the basis of our results, we propose that the growth defect of hph1D hph2D yeast on ZnCl 2 likely results from a V-ATPase independent mechanism. It is unclear whether the zinc sensitivity in Hph mutants results from an effect on vacuole-localized Zn 21 transportation or some other mechanism.
Genome-wide screens for zinc or calcium (at pH 7.5) sensitivity have found genes that do not directly contribute to V-ATPase function yet show sensitivity to excess metals (Sambade et al. 2005; Pagani et al. 2007 ). An example is deletion of the vacuolar zinc transporter Zrc1p, which confers zinc sensitivity even though vacuolar acidification is normal (data not shown). Also, a loss of the serine protease Kex2p results in both calcium and zinc sensitivity yet does not cause any defect in vacuolar acidification (Sambade et al. 2005) . Identifying which genetic pathways are directly linked to metal sensitivity independent of V-ATPase function will require further study.
The Orm proteins are also functionally redundant, integral membrane proteins that localize to the ER in yeast (data not shown). Since loss of both ORM genes caused a reduction in vacuolar acidification and V-ATPase enzyme activity in the context of the vma21QQ mutation, we propose that Orm1p and Orm2p are necessary for full V-ATPase function. However, the phenotype associated with disruption of only the ORM genes does not completely phenocopy a loss of other assembly factors (such as PKR1 or the combination vma21QQ voa1D). Key differences highlight the potential mechanism through which the Orm proteins may impact the V-ATPase including the lack of an apparent V 0 assembly defect. It is unlikely that the Orm proteins transiently participate in V 0 assembly of the V-ATPase, as we were unable to determine any physical association of Orm2p with the Vma21p-V 0 subcomplex (data not shown).
We also examined whether a variety of cargo proteins (including both subdomains of the V-ATPase) were aberrantly targeted upon a loss of the Orm proteins. Resident ER (Vma21p), Golgi (Vps10p), plasma membrane (Pma1p, Ste3p, and Snf3p), and vacuolar proteins (Sna3p, Zrt3p, Vcx1p, Pho8p, and Cps1p) did not display changes in localization patterns compared to wild-type yeast (data not shown). Consistent with these data, we found normal V 1 V 0 localization of the V-ATPase to the vacuole membrane, suggesting an indirect involvement of Orm1p and Orm2p. A more likely scenario involves perturbation of V-ATPase function through other cellular pathways.
Recently, two studies have characterized Orm1p and Orm2p as negative regulators of sphingolipid synthesis (Breslow et al. 2010; Han et al. 2010) . Both groups have reported that the Orm proteins physically associate with and regulate the SPT complex in the ER. Interestingly, inhibition of the SPT enzyme complex was found to alleviate phenotypes associated with a loss of ORM1 and ORM2, including cold sensitivity and sensitivity to tunicamycin (Han et al. 2010) . Our data are consistent with these findings and it is likely that ORM1 and ORM2 indirectly affect V-ATPase function through perturbation of sphingolipid production. This interpretation is in agreement with the effect of the lipid environment on the assembly, transport, or function of various enzymes including the amino acid permease Gap1p (Lauwers et al. 2007) , uracil permease Fur4p (Hearn et al. 2003) , and plasma membrane H 1 -ATPase Pma1p (Wang and Chang 2002; Gaigg et al. 2006) . Also, deletion of two components of the fatty acid elongation pathway required for sphingolipid C26 acyl group synthesis ( fen1D and sur4D) resulted in perturbation of vacuolar acidification, a decrease in V-ATPase enzyme activity, and a functionally compromised V 1 domain (Chung et al. 2003) . This previous study reported destabilization of the V-ATPase; specifically, a portion of the V 1 subdomain dissociates from the membrane during vacuole membrane preparation of the sur4D mutant. Since loss of the Orm proteins results in a similar change in the lipidome as sur4D yeast (Breslow et al. 2010) , loss of the V 1 subdomain during vacuolar preparation could explain why vma21QQ orm1D orm2D cells display levels of V-ATPase activity similar to vma21Q voa1D yeast but higher vacuolar acidification in vivo. Since they are negative regulators, deletion of ORM1 and ORM2 results in an increase in the sphingolipid composition of the cell (Breslow et al. 2010) . Loss of the Orm proteins results in a subtle decrease in V-ATPase function and this differs from both the sur4D and fen1D mutations. However, this connection between sphingolipid regulation and V-ATPase function would have been missed in previous forward genetic screens. Overproduction of sphingolipids likely results in an altered lipid environment for the V-ATPase as sphingolipids play crucial roles for many cellular functions (Hanada 2003; Cowart and Obeid 2007) .
The use of sensitized genetic backgrounds to identify factors that have subtle effects on V-ATPase function has revealed genes involved in a variety of cellular pathways. We have identified the Orm proteins and implicated sphingolipid regulation as important contributors to full V-ATPase enzyme activity. Future genome-wide screens that specifically assay V-ATPase function will aid in separating genes, like HPH1 and HPH2, which do not directly affect enzyme activity, from those that are dedicated effectors of V-ATPase assembly, transport, or enzyme function. Finally, further characterization of the precise mechanism by which alteration of sphingolipids and the cellular lipid composition affect function of the V-ATPase will be of great interest and provide a more complete understanding of this crucial molecular machine.
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Note added in proof:
A very recent study implicated HPH1/HPH2 in V-ATPase biogenesis (Piña et al., Euk. Cell, 10: 63-71, 2011) . Piña et al. report that Vph1p is degraded equally rapidly in vma21D and hph1D hph2D mutants (Piña et al. 2011 ; Figure 3D ), in contrast to our findings that Vph1p levels are normal in hph1D hph2D mutants, but significantly reduced in vma21D mutants (our Figure 5) . Rapid turnover of Vph1p in hph1D hph2D yeast is inconsistent with nearnormal growth in the presence of 250 mM Ca 21 (Piña et al. 2011; Figure 3A ) and 4 mM Zn 21 (our Figure 2C) . Additionally, the stability of Vph1p in wild-type yeast determined by Piña et al. is inconsistent with previously published measurements (>5 hours; Graham et al., 1998) . Finally and most importantly, our study reports that vacuoles from hph1D hph2D yeast (in two different genetic backgrounds) have 100% of wild-type V-ATPase activity, whereas vma21D cells have no measureable V-ATPase activity (our Table 4 ). In contrast to Piña et al., based on our data, we conclude that the HPH1/HPH2 genes do not play a role in V-ATPase biogenesis. Gene Ontology (GO) analysis was performed using the Saccharomyces Genome Database (SGD) "Gene Ontology Term
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Finder" (v. 0.83). Of the 538 genes identified from our three SGA screens, 492 were included within the GO analysis (overlapping ORFs were excluded). The GO term ID# and GO categories are listed. The cluster and background frequency are shown for each GO term and hits with p-values of less than 0.01 were included. Results are listed beginning with GO categories with the lowest p-values.
